A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

by | Jul 6, 2026 | Clinical Trials | 0 comments

​ Conditions: Vitiligo

Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment

Sponsors: Minghui Pharmaceutical (Hangzhou) Ltd

Not yet recruiting Conditions: Vitiligo
Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment
Sponsors: Minghui Pharmaceutical (Hangzhou) Ltd
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *